For nearly half a century, the debate over abortion has shifted back to state control, following the Supreme Court’s pivotal Dobbs decision three years ago. The anti-abortion movement is now facing a new landscape. Surprisingly, abortion rates, rather than declining, have shown signs of an increase.
Anti-abortion advocates are now, it seems, more divided. They’re focusing on new strategies, like cutting funding to Planned Parenthood—the largest abortion provider in the U.S.—and limiting access to abortion-inducing medications. Engaging with political candidates who align with their views is also a key tactic for them.
In an interview, Marjorie Dannenfelser, president of SBA Pro-Life America, expressed that Dobbs triggered a “revolution,” yet acknowledged there is still much work to be done. According to the Charlotte Lozier Institute, the year following Dobbs witnessed a rise in abortions, with at least 1.1 million abortions occurring from mid-2023 to mid-2024.
Recently, statements from Planned Parenthood highlighted concerns. They suggested that new legislation aimed at restricting Medicaid funds for abortions could lead to the closure of nearly 200 of their facilities, which would significantly limit access to not just abortion services but also essential healthcare like cancer screenings and birth control.
Meanwhile, the FDA relaxed regulations for mifepristone, a medication used to terminate pregnancies. Now, individuals can receive it by mail, even in states where abortion is restricted. Dannenfelser described this broad access to abortion pills as a “direct attack” on state rights and advocated for stronger pro-life laws to counteract this trend.
Dannenfelser also mentioned that her organization is working closely with fundraising efforts in anticipation of the upcoming 2024 elections. They hope to sustain a pro-life majority in Congress. However, there are those within the movement who believe that the current administration could and should be more supportive.
Former President Donald Trump has been noted for his complicated relationship with pro-life advocates, having previously defended activists arrested for blocking access to abortion clinics. While he appointed judges who supported overturning Roe v. Wade, his administration has also been involved in cases that challenge regulations on abortion drugs.
Katie Zavios, the national director of the American Life League, expressed skepticism about Trump’s commitment to pro-life issues. She criticized the current landscape of mifepristone distribution and called for a more proactive stance from the government, warning that without significant leadership, the situation might become chaotic.
Zavios emphasized the need for foundational change, advocating for instilling values in youth that foster a pro-life mindset. Ultimately, she expressed uncertainty about whether the legal battles surrounding abortion will shift public sentiment enough to uphold the dignity of life for all individuals.
